V A Sansone

Summary

Affiliation: University of Milan
Country: Italy

Publications

  1. ncbi Management and treatment of Andersen-Tawil syndrome (ATS)
    Valeria Sansone
    Department of Neurology, University of Milan, IRCCS Policlinico San Donato, Milan, Italy 20097
    Neurotherapeutics 4:233-7. 2007
  2. ncbi Measuring quality of life impairment in skeletal muscle channelopathies
    V A Sansone
    Department of Neurology, University of Milan, IRCCS Policlinico San Donato, Milan, Italy
    Eur J Neurol 19:1470-6. 2012
  3. ncbi Contrast-induced seizures after cardiac catheterization in a 6-year-old child
    Valeria Sansone
    Department of Neurology, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy
    Pediatr Neurol 36:268-70. 2007
  4. ncbi Long-term follow-up free of ventricular fibrillation recurrence after resuscitated cardiac arrest in a myotonic dystrophy type 1 patient
    Valeria A Sansone
    Department of Neurology, University of Milan, IRCCS Policlinico San Donato, Italy
    Europace 11:1243-4. 2009
  5. ncbi Italian validation of INQoL, a quality of life questionnaire for adults with muscle diseases
    V A Sansone
    Department Neurology, University of Milan, IRCCS Policlinico San Donato, Italy
    Eur J Neurol 17:1178-87. 2010
  6. ncbi Cerebral involvement in myotonic dystrophies
    Giovanni Meola
    Department of Neurology, University of Milan, IRCCS Policlinico San Donato, San Donato Hospital, Via Morandi 30, 20097 San Donato Milanese, Milan, Italy
    Muscle Nerve 36:294-306. 2007
  7. ncbi Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome)
    Martin Tristani-Firouzi
    Division of Pediatric Cardiology, University of Utah, Salt Lake City, Utah 84112, USA
    J Clin Invest 110:381-8. 2002
  8. ncbi Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect
    Linda L Bachinski
    Section of Cancer Genetics, Department of Molecular Genetics, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
    Am J Hum Genet 73:835-48. 2003

Collaborators

  • G Apolone
  • Giovanni Meola
  • M R Rose
  • G Siciliano
  • Luigi De Ambroggi
  • Riccardo Cappato
  • A Palmieri
  • B Udd
  • Linda L Bachinski
  • Martin Tristani-Firouzi
  • Armand Bottani
  • Ralf Krahe
  • Carmen Navarro
  • Fred A Wright
  • Andre Kohler
  • Mark T Rogers
  • Richard T Moxley
  • Mark D Shriver
  • Guillaume Bassez
  • Riitta Sallinen
  • Shanxiang Zhang
  • Thomas Wieser
  • Josep Gamez
  • Karin Jurkat-Rott
  • Peter S Harper
  • Charles A Thornton
  • Frank Lehmann-Horn
  • Maija Wessman
  • Bruno Eymard
  • Louis J Ptacek
  • Anna Fidzianska
  • Hubert Kwiecinski
  • Matthew R Donaldson
  • Ying-Hui Fu
  • Angelika Hahn
  • Rabi Tawil
  • Judy L Jensen
  • Said Bendahhou
  • Nikki Plaster
  • Ying Hui Fu

Detail Information

Publications8

  1. ncbi Management and treatment of Andersen-Tawil syndrome (ATS)
    Valeria Sansone
    Department of Neurology, University of Milan, IRCCS Policlinico San Donato, Milan, Italy 20097
    Neurotherapeutics 4:233-7. 2007
    ..We review the clinical, laboratory, and genetic features of this disorder with particular emphasis on treatment and management...
  2. ncbi Measuring quality of life impairment in skeletal muscle channelopathies
    V A Sansone
    Department of Neurology, University of Milan, IRCCS Policlinico San Donato, Milan, Italy
    Eur J Neurol 19:1470-6. 2012
    ..The aims of our study were to assess QoL in skeletal muscle channelopathies (SMC) using INQoL (individualized QoL) and SF-36 questionnaires...
  3. ncbi Contrast-induced seizures after cardiac catheterization in a 6-year-old child
    Valeria Sansone
    Department of Neurology, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy
    Pediatr Neurol 36:268-70. 2007
    ....
  4. ncbi Long-term follow-up free of ventricular fibrillation recurrence after resuscitated cardiac arrest in a myotonic dystrophy type 1 patient
    Valeria A Sansone
    Department of Neurology, University of Milan, IRCCS Policlinico San Donato, Italy
    Europace 11:1243-4. 2009
    ..We describe a 38-year-old man in whom the diagnosis of DM1 was made 8 years after occurrence of cardiac arrest owing to ventricular fibrillation and discuss management of DM1 patients at risk for sudden cardiac death...
  5. ncbi Italian validation of INQoL, a quality of life questionnaire for adults with muscle diseases
    V A Sansone
    Department Neurology, University of Milan, IRCCS Policlinico San Donato, Italy
    Eur J Neurol 17:1178-87. 2010
    ..The purpose of our work was: (i) To validate INQoL in Italy on a larger sample of adult patients with muscle diseases (ii) to compare INQoL to SF-36...
  6. ncbi Cerebral involvement in myotonic dystrophies
    Giovanni Meola
    Department of Neurology, University of Milan, IRCCS Policlinico San Donato, San Donato Hospital, Via Morandi 30, 20097 San Donato Milanese, Milan, Italy
    Muscle Nerve 36:294-306. 2007
    ....
  7. ncbi Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome)
    Martin Tristani-Firouzi
    Division of Pediatric Cardiology, University of Utah, Salt Lake City, Utah 84112, USA
    J Clin Invest 110:381-8. 2002
    ..These findings suggest that the substrate for arrhythmia susceptibility in AS is distinct from the other forms of inherited LQT syndrome...
  8. ncbi Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect
    Linda L Bachinski
    Section of Cancer Genetics, Department of Molecular Genetics, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
    Am J Hum Genet 73:835-48. 2003
    ..Taken together, these data suggest a single founding mutation in DM2 patients of European origin. We estimate the age of the founding haplotype and of the DM2 (CCTG) expansion mutation to be approximately 200-540 generations...